Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2010 (2010), Article ID 369654, 3 pages
http://dx.doi.org/10.1155/2010/369654
Research Article

Unnecessary Workup of Asymptomatic Neonates in the Era of Group B Streptococcus Prophylaxis

1Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912, USA
2Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA
3Department of Sugery, Mercer University School of Medicine, Macon, GA 31207, USA
4Georgia Prevention Instuite, Medical College of Georgia, Augusta, GA 30912, USA

Received 10 November 2009; Revised 14 May 2010; Accepted 19 May 2010

Academic Editor: Bryan Larsen

Copyright © 2010 Brad Buckler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. F. Tumbaga and A. G. Philip, “Perinatal Group B streptococcal infections and the new Guidelines: an update,” NeoReviews, vol. 7, pp. e534–e530, 2006. View at Google Scholar
  2. A. L. Anderson-Berry and L. L. Bellig, “Neonatal sepsis,” Emedicine, 2008. View at Google Scholar
  3. M. C. Ottolini, K. Lundgren, L. J. Mirkinson, S. Cason, and M. G. Ottolini, “Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn,” Pediatric Infectious Disease Journal, vol. 22, no. 5, pp. 430–434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Schrag, R. Gorwitz, K. Fultz-Butts, and A. Schuchat, “Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC,” Morbidity and Mortality Weekly Report, vol. 51, no. 11, pp. 1–22, 2002. View at Google Scholar · View at Scopus
  5. Center for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infection Program Network, Group B Streptococcus, 2000.
  6. Center for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infection Program Network, Group B Streptococcus, 2006.
  7. R. A. Saifer, S. H. Robins, C. M. Picone, and N. Tafari, “Blood culture screening of newborns at risk for early onset neonatal group B streptococcal disease,” Pediatric Research, vol. 51, supplement, p. 304A, 2002. View at Google Scholar
  8. M. De Cueto, M.-J. Sanchez, A. Sampedro, J.-A. Miranda, A.-J. Herruzo, and M. Rosa-Fraile, “Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus,” Obstetrics and Gynecology, vol. 91, no. 1, pp. 112–114, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. A. R. McNanley, J. C. Glantz, D. J. Hardy, and D. Vicino, “The effect of intrapartum penicillin on vaginal group B streptococcus colony counts,” American Journal of Obstetrics and Gynecology, vol. 197, no. 6, pp. 583–e1, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. L. Bloom, S. M. Cox, R. E. Bawdon, and L. C. Gilstrap, “Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved?” American Journal of Obstetrics and Gynecology, vol. 175, no. 4, pp. 974–976, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Campbell, A. Eddy, B. Darlow, P. Stone, and K. Grimwood, “The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party,” New Zealand Medical Journal, vol. 117, no. 1200, 2004. View at Google Scholar